Lack of association between the rs2294008 polymorphism in the prostate stem cell antigen gene and colorectal neoplasia: A case-control and immunohistochemical study

被引：10

作者：

Christopher Smith

Paul Lochhead

Umesh Basavaraju

Georgina L Hold

Nicky Fyfe

Graeme I Murray

Emad M El-Omar

机构：

[1] Gastrointestinal Research Group, Institute of Medical Sciences, University of Aberdeen, Aberdeen

[2] Department of Pathology, University of Aberdeen, Aberdeen

[3] Institute of Medical Sciences, University of Aberdeen, Aberdeen

来源：

BMC Research Notes | / 5卷 / 1期

关键词：

Adenoma; Case control study; Colon cancer; Colorectal cancer; Colorectal neoplasia; Immunohistochemistry; Polyp; Prostate stem cell antigen; Rectal cancer; Single nucleotide polymorphism;

D O I：

10.1186/1756-0500-5-371

中图分类号：

学科分类号：

摘要：

Background: Prostate stem cell antigen (PSCA) has been implicated in the pathogenesis of several solid tumours, either due to changes in protein expression, or through association with the rs2294008 polymorphism in the PSCA gene. To our knowledge, the role of PSCA in the development of colorectal neoplasia has not been explored. We performed a genotyping study to assess for associations between the rs2294008 polymorphism and risk of adenomatous polyps and colorectal cancer. DNA samples were available from 388 individuals with colorectal neoplasia and 496 controls, all of whom had undergone screening colonoscopy. In addition, we performed immunohistochemical staining for PSCA in colonic tissue representing all stages of the adenoma-carcinoma sequence. Results: No genotypic associations were found between the rs2294008 polymorphism and the risk of colorectal adenomata or cancer. Immunohistochemical staining did not reveal any alteration in PSCA expression accompanying the adenoma-carcinoma sequence. Conclusion: From these data it seems unlikely that PSCA has a role in the initiation or progression of colorectal neoplasia. © 2012 Smith et al.; licensee BioMed Central Ltd.

引用

共 29 条

[1]

Reiter R.E., Gu Z., Watabe T., Thomas G., Szigeti K., Davis E., Wahl M., Nisitani S., Yamashiro J., Le Beau M.M., Loda M., Witte O.N., Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer, Proceedings of the National Academy of Sciences of the United States of America, 95, 4, pp. 1735-1740, (1998)

[2]

Gu Z., Thomas G., Yamashiro J., Shintaku I.P., Dorey F., Raitano A., Witte O.N., Said J.W., Loda M., Reiter R.E., Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer, Oncogene, 19, 10, pp. 1288-1296, (2000)

[3]

Han K.-R., Seligson D.B., Liu X., Horvath S., Shintaku P.I., Thomas G.V., Said J.W., Reiter R.E., Prostate stem cell antigen expression is associated with gleason score, seminal vesicle invasion and capsular invasion in prostate cancer, Journal of Urology, 171, 3, pp. 1117-1121, (2004)

[4]

Liu W.K., Jiang X.Y., Zhang Z.X., Expression of PSCA, PIWIL1, and TBX2 in endometrial adenocarcinoma, Onkologie, 33, 5, pp. 241-245, (2010)

[5]

Elsamman E.M., Fukumori T., Tanimoto S., Nakanishi R., Takahashi M., Toida K., Kanayama H.-O., The expression of prostate stem cell antigen in human clear cell renal cell carcinoma: A quantitative reverse transcriptase-polymerase chain reaction analysis, BJU International, 98, 3, pp. 668-673, (2006)

[6]

Cao D., Ji H., Ronnett B.M., Expression of mesothelin, fascin, and prostate stem cell antigen in primary ovarian mucinous tumors and their utility in differentiating primary ovarian mucinous tumors from metastatic pancreatic mucinous carcinomas in the ovary, International Journal of Gynecological Pathology, 24, 1, pp. 67-72, (2005)

[7]

Amara N., Palapattu G.S., Schrage M., Gu Z., Thomas G.V., Dorey F., Said J., Reiter R.E., Prostate stem cell antigen is overexpressed in human transitional cell carcinoma, Cancer Research, 61, 12, pp. 4660-4665, (2001)

[8]

Argani P., Rosty C., Reiter R.E., Wilentz R.E., Murugesan S.R., Leach S.D., Ryu B., Skinner H.G., Goggins M., Jaffee E.M., Yeo C.J., Cameron J.L., Kern S.E., Hruban R.H., Discovery of new markers of cancer through serial analysis of gene expression: Prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma, Cancer Research, 61, 11, pp. 4320-4324, (2001)

[9]

Kawaguchi T., Sho M., Tojo T., Yamato I., Nomi T., Hotta K., Hamada K., Suzaki Y., Sugiura S., Kushibe K., Nakajima Y., Taniguchi S., Clinical significance of prostate stem cell antigen expression in non-small cell lung cancer, Jpn J Clin Oncol, 40, 4, pp. 319-326, (2010)

[10]

Geiger K.D., Hendruschk S., Rieber E.P., Morgenroth A., Weigle B., Juratli T., Senner V., Schackert G., Temme A., The prostate stem cell antigen represents a novel glioma-associated antigen, Oncol Rep, 26, 1, pp. 13-21, (2011)

← 1 2 3 →